Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sunbeam Biotech is a high-tech biotechnology company specializing in the application of microbiome technology and metagenomic next-generation sequencing (mNGS). The company provides comprehensive solutions for clinical pathogen detection, gut microbiome analysis, and precision medicine research. Leveraging its proprietary Sunbeam bioinformatics platform, the company offers high-throughput sequencing services and has developed a pipeline of in vitro diagnostic (IVD) kits for rapid and accurate identification of infectious agents. Sunbeam Biotech is a key player in the Chinese microbiome market, serving both clinical institutions and academic researchers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sunbeam.